I had the privilege of trying the Micro-ECoG from Blackrock. I was quite impressed how professional it looked. It was robust, yet extremely delicate. We had a challenging surgery and the device worked solidly first time.
We weren’t happy with the standard of care and now we are working with Blackrock on next-generation devices.
I have made it my life’s ambition to address dementia. Blackrock has helped me understand the challenges I face in building a venture in neurotech.
Blackrock is the clear technology leader for human microelectrode arrays. They are the only ones whose devices have been implanted chronically in humans. If you want single neuron resolution in people, you can’t use anyone else’s technology at this point.
“I said, ‘Cursor go up to the top right.’ And it did, and now I can control it all over the screen. It will give me a sense of independence.”
“When they say, that wasn’t a
computer doing this, it was all you,
I just cant stop smiling, its just that cool!
I’m moving things again.”
First person to control a robotic arm. 10 years earlier, she was diagnosed with spinocerebellar degeneration
“My experience with the NeuroPort Array
has shown even after a traumatic injury,
restoration of paralyzed muscles is
possible and can provide Independence.”
Sustained a spinal cord injury in 2010 and has the longest chronic implant of the NeuroPort Array since June 2014.
“Blackrock’s ‘end-to-end expertise’
and FDA mindfulness gives us
the comfort for doing the cutting-edge
experiments that we do.”
Sustained a spinal cord injury in a 2004 automobile accident and was implanted November 2014 achieving sensory feedback through intracortical microstimulation